Takeda, Toshikazu

J-GLOBAL         Last updated: Oct 2, 2019 at 16:07
Takeda, Toshikazu
Keio University
School of Medicine Department of Urology
Job title
Senior Assistant Professor (Non-tenured)/Assistant Professor (Non-tenured)
博士(医学)(Keio University)

Research Areas



Apr 1996
Mar 2002
医学部, Keio University

Awards & Honors

Apr 2019
Reviewer of the journal in 2018, International Journal of Urology
Feb 2019
前立腺癌に対するFocal Therapy候補者予測モデルの構築, 優秀研究課題, 公益財団法人 前立腺研究財団
Mar 2018
Outstanding Contribution in Reviewing, International Journal of Surgery
Winner: Toshikazu Takeda

Published Papers

Ogihara K., Kikuchi E., Okazaki S., Hagiwara M., Takeda T., Matsumoto K., Kosaka T., Mikami S., Saya H., Oya M.
Cancer Science   110(4) 1431-1441   Apr 2019
© 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. The prognostic role of CD44v9, a variant isoform of CD44 and a new cell surface marker of cancer stem cells, remains uncl...
Takamatsu K., Matsumoto K., Shojo K., Tanaka N., Takeda T., Morita S., Kosaka T., Mizuno R., Shinojima T., Kikuchi E., Asanuma H., Oya M.
Urologic Oncology: Seminars and Original Investigations      2019
© 2019 Elsevier Inc. Objective: To investigate the influence of the zonal origin of prostate cancer and extraprostatic extension on biochemical recurrence (BCR). Patients and methods: We included 638 consecutive patients undergoing radical prostat...
Matsumoto K., Akita H., Narita K., Hashiguchi A., Takamatsu K., Takeda T., Kosaka T., Mizuno R., Kikuchi E., Oya M., Jinzaki M.
Prostate Cancer and Prostatic Diseases      2019
© 2019, Springer Nature America, Inc. Background: Tumor contact length (TCL) is defined as the extent of contact between prostate cancer and the prostatic capsule, and its predictive value for microscopic extraprostatic extension (EPE) has been re...
Takamatsu K., Mizuno R., Tanaka N., Takeda T., Morita S., Matsumoto K., Kosaka T., Shinojima T., Kikuchi E., Asanuma H., Oyama M., Mikami S., Oya M.
International Journal of Clinical Oncology      2019
© 2019, Japan Society of Clinical Oncology. Background: The later-line treatment of metastatic renal cell carcinoma (mRCC) has been drastically changing by the development of immune-oncology drugs and molecular targeted treatment in recent years. ...
Mazaheri, Y., Shukla-Dave, A., Goldman, D. A., Moskowitz, C. S., Takeda, T., Reuter, V. E., Akin, O. and Hricak, H.
Magn Reson Imaging      Aug 2018
PURPOSE: To retrospectively measure metabolic ratios and apparent diffusion coefficient (ADC) values from 3-Tesla MR spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) in benign and malignant peripheral zone (PZ) prostate tissue, as...


Takeda T., Benfante N., Assel M., Mulhall J., Oya M., Touijer K.
International Journal of Urology   26(9) 934-935   Sep 2019